Johnson & Johnson (JNJ)

156.22
2.80 1.76
NYSE
Prev Close 159.02
Open 158.25
Day Low/High 156.06 / 158.90
52 Wk Low/High 109.16 / 165.16
Volume 8.48M
Exchange NYSE
Shares Outstanding 2628.68B
Market Cap 418.80B
P/E Ratio 28.74
Div & Yield N.A. (N.A)
Cramer: Stocks May Be Cheaper Than We Think

Cramer: Stocks May Be Cheaper Than We Think

There's a case to be made for underpricing, even in this market.

Should You Listen to a Talking Head?

"Everyone is putting money in the market, so you might as well follow."  -- CNBC talking head  In the aggregate, the markets were uneventful -- with another remarkably narrow range in the S&P Index.  But there were some major movers.  On the upside,...

UnitedHealth and J&J Drive Dow to 23,000 but Rest of Market Wavers

UnitedHealth and J&J Drive Dow to 23,000 but Rest of Market Wavers

Positive earnings from UnitedHealth Group and Johnson & Johnson sweep the Dow Jones Industrial Average to top 23,000 and hit a new all-time high.

Cramer: Getting Out the Bad News Gives a Post-Earnings Boost

Cramer: Getting Out the Bad News Gives a Post-Earnings Boost

When management gets ahead of bad news, it allows a stock to prosper when the company reports earnings.

Cramer: This Market's Like a Seafood Restaurant, Always a Catch of the Day

Cramer: This Market's Like a Seafood Restaurant, Always a Catch of the Day

Today that catch was McDonald's, tomorrow it will probably be something different.

My Takeaways and Observations

"While options can give market participants the protection they are intended to provide, they can also increase the degree of a counter move, once it gets going, as those who wrote the protection scramble to unwind their own exposure." -- Kass Diary...

Cramer: These Research Upgrades Are Actually Having an Impact

Cramer: These Research Upgrades Are Actually Having an Impact

Colgate, First Data and Snap, among other stocks, could rise on these analyst actions, and here's why.

Johnson & Johnson Shares May Need a Band-Aid Before They Can Rally

Johnson & Johnson Shares May Need a Band-Aid Before They Can Rally

I continue to have my doubts about JNJ rallying to new highs.

Is Johnson & Johnson Sitting Out the Rally?

Is Johnson & Johnson Sitting Out the Rally?

When a stock isn't doing anything while the market is up, you have to ask questions.

Cramer: Sellers May Be Ready to Give You Some Bargains

Cramer: Sellers May Be Ready to Give You Some Bargains

The third day of a trading period is typically the day we see sellers, after two up days.

Here's When to Go Long Johnson & Johnson

Here's When to Go Long Johnson & Johnson

We remain positive on JNJ.

Positive Signs in Drug Distribution

Positive Signs in Drug Distribution

Blockbuster drugs still need companies to deliver them.

Cramer: 5 Stocks That Turned Negatives Into Positives

Cramer: 5 Stocks That Turned Negatives Into Positives

This is the kind of action you get when you have a real bull market.

Cramer: Is There a Human Element to This Rally?

Cramer: Is There a Human Element to This Rally?

It could be all machine-to-machine and not much more than that.

The Best Companies for Women

The Best Companies for Women

Working Mother and the National Association of Female Executives surveyed companies and found the best ones that do right by women. Find out who you should be working for.

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'

Johnson & Johnson had a very good acquisition

Johnson & Johnson Is Getting Ready for Another Upside Breakout

Johnson & Johnson Is Getting Ready for Another Upside Breakout

A cover shorts signal was triggered, and an outright go long signal could follow soon.

Cramer: Got the Apple-FANG Blues? Look for a Rotation

Cramer: Got the Apple-FANG Blues? Look for a Rotation

There's one going on now.

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback.

Cramer: There Should Be More Takeovers Where These Came From

Cramer: There Should Be More Takeovers Where These Came From

Buying's good for the acquirers, which should give other companies ideas.

Cramer: Ready for the New Normal? Here It Is

Cramer: Ready for the New Normal? Here It Is

Problem areas such as the dollar, oil and retail move to the foreground.

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.

How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery

How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery

JNJ's Chief Medical Officer fell in love with science after spending so much time in her family's bakery

My Takeaways and Observations

"I wanted a perfect ending. Now I've learned, the hard way, that some poems don't rhyme, and some stories don't have a clear beginning, middle, and end. Life is about not knowing, having to change, taking the moment and making the best of it, withou...

President Trump Outlines Plans for Fighting in Afghanistan

President Trump Outlines Plans for Fighting in Afghanistan

President Donald Trump said troop levels will be ramped up but no numbers were given.

Cramer: How Picking Stocks Is Like Fantasy Football

Cramer: How Picking Stocks Is Like Fantasy Football

Hear me out: The same lessons and disciplines are useful in both.

Don't Get Out of Joint

Don't Get Out of Joint

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.

CEOs Dump Donald Trump

CEOs Dump Donald Trump

CEOs exit President's Council after Charlottesville response

Chart Signals End to Dollar Trend

Chart Signals End to Dollar Trend

The dollar index is now in an area of strong support.